Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) and CE Mark approval of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) system. The Emblem S-ICD system is a treatment option that provides protection for patients at risk of sudden cardiac arrest (SCA), yet leaves the heart and vasculature untouched, minimizing the risk of complications associated with conventional transvenous implantable cardioverter-defibrillators (TV-ICDs).

Philips Healthcare launched IntelliSpace Cardiovascular at the American College of Cardiology (ACC) 2015 meeting. The Web-enabled cardiovascular information system (CVIS) offers a single integrated workspace that produces a holistic view of the patient's care continuum across the entire cardiovascular service line. The new solution provides cardiologists with sophisticated tools for diagnosis and planning of patient cardiovascular care. The system uses an intuitive icon based tab system to easily sort and recognize various types of exams, imaging and reports.

 

CTA, CCTA, CT angiography, ACC.15, ACC 2015, SCOT-HEART

Use of computed tomography coronary angiography (CTA), which provides 3-D images of the heart, coupled with standard care allows doctors to more accurately diagnose coronary artery disease in patients presenting with chest pain. This has led to more appropriate follow-up testing and treatments, according to research presented at the American College of Cardiology (ACC) 2015 Annual Scientific Session. Data also showed a trend toward a lower incidence of heart attacks among the group receiving CT scans, compared to usual care.
TriGuard, Keystone, embolic protection, TAVR

March 19, 2015 — An investigational device that deflects debris away from the brain during transcatheter aortic valve replacement (TAVR) seems to improve in-hospital safety outcomes and cognitive scores at discharge, according to preliminary findings from the small, randomized DEFLECT III study presented at the American College of Cardiology (ACC) 2015 Annual Scientific Session. 

New study results from The Cardiothoracic Surgical Trials Network (CTSN) show the addition of surgical ablation during mitral valve surgery reduces the occurrence of atrial fibrillation in patients.

SecondOpinionExpert has expanded its online medical second opinions platform by launching an electronic health record (EHR) mobile app for iPhone, iPad and Android devices.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now